These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 107360)
1. [Sputum positive conversion among retreatment cases with pulmonary tuberculosis converted to negative by the use of rifampicin (author's transl)]. Ito F; Okochi T; Yamazaki M; Yamamoto Y; Kondo K; Konishiike J; Asahi T Kekkaku; 1979 Jan; 54(1):37-42. PubMed ID: 107360 [No Abstract] [Full Text] [Related]
2. [Bacteriological relapse among the previously treated advanced pulmonary tuberculosis patients whose sputum converted to negative by the rifampicin treatment, with special reference to the duration of rifampicin administration (author's transl)]. Yamamoto M; Morishita M; Hirano Y; Nagata A; Yazaki M Kekkaku; 1974 Jul; 49(7):195-9. PubMed ID: 4214961 [No Abstract] [Full Text] [Related]
3. [Results of follow-up on advanced cases of pulmonary tuberculosis converted to negative with rifampicin treatment]. Yamamoto M; Isoe K; Nakamura H; Hirose H; Izumi S Kekkaku; 1972 Nov; 47(11):393-7. PubMed ID: 4630902 [No Abstract] [Full Text] [Related]
4. [Short course chemotherapy for pulmonary tuberculosis with duration for 6 months after sputum negative conversion. (Report 1)--Report of the 19--20th A series of controlled trial of chemotherapy--(author's transl)]. Kekkaku; 1979 Jan; 54(1):51-61. PubMed ID: 107362 [No Abstract] [Full Text] [Related]
5. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. I. Some considerations on the sputum conversion rate and the emergence of drug resistance]. Baba H; Takahashi R; Azuma Y Kekkaku; 1971 Nov; 46(11):429-35. PubMed ID: 5004056 [No Abstract] [Full Text] [Related]
6. [The relation between bacilli negative conversion rate and the number of combined sensitive antituberculous drugs in intermittent administration of rifampicin for severe pulmonary tuberculosis]. Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M Kekkaku; 1973 Jul; 48(7):297-302. PubMed ID: 4200058 [No Abstract] [Full Text] [Related]
7. [A long-term observation on previously treated cases of pulmonary tuberculosis retreated with rifampicin for more than six months (author's transl)]. Tamura M; Takazawa N; Asada T; Ikegaki H; Yamada M; Kushiro S; Tada T Kekkaku; 1979 May; 54(5):285-95. PubMed ID: 113607 [No Abstract] [Full Text] [Related]
8. [Rifampicin treatment for pulmonary tuberculosis--effectiveness of rifampicin on tubercle bacilli in pulmonary lesions (author's transl)]. Kameda K; Okamura S; Yamamoto S; Iwai K Kekkaku; 1975 Jul; 50(7):185-9. PubMed ID: 810614 [No Abstract] [Full Text] [Related]
9. Rifampicin in the retreatment and original treatment of advanced pulmonary tuberculosis. Gyselen A Bull Int Union Tuberc; 1970 Jun; 43():60-3. PubMed ID: 4987555 [No Abstract] [Full Text] [Related]
10. [Effect of rifampicin on the L transformation of a mycobacterial population in patients with destructive pulmonary tuberculosis]. Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE; Kiazimova LM Probl Tuberk; 1986; (9):31-4. PubMed ID: 3097632 [No Abstract] [Full Text] [Related]
11. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation]. Masztalerz J Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043 [No Abstract] [Full Text] [Related]
12. [Bacteriologic test during rifampicin treatment]. Ivaldy F Rev Tuberc Pneumol (Paris); 1969; 33(6):818-20. PubMed ID: 4989191 [No Abstract] [Full Text] [Related]
13. [Direct genetic analysis of the rifampicin resistance of M. tuberculosis isolates in sputum samples]. Generozov EV; Akopian TA; Vladimirskiĭ MA; Shipina LK; Irtuganova OA; Govorun VM Probl Tuberk Bolezn Legk; 2003; (4):49-52. PubMed ID: 12774423 [TBL] [Abstract][Full Text] [Related]
14. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
15. [The smear-positive and culture-negative phenomenon of mycobacteria in sputum specimens in relation to the problems on the detection of mycobacteria (author's transl)]. Kudoh S Kekkaku; 1981 Jun; 56(6):291-9. PubMed ID: 6795379 [No Abstract] [Full Text] [Related]
16. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion]. Nowak D; Radenbach D; Magnussen H Pneumologie; 1990 Feb; 44 Suppl 1():497-8. PubMed ID: 2114634 [TBL] [Abstract][Full Text] [Related]
17. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment. Kim TC; Blackman RS; Heatwole KM; Kim T; Rochester DF Am Rev Respir Dis; 1984 Feb; 129(2):264-8. PubMed ID: 6421211 [TBL] [Abstract][Full Text] [Related]
18. [Clinical results of retreatment using rifampicin for more than 12 months for pulmonary tuberculosis (author's transl)]. Urakami E; Nagasawa S Kekkaku; 1973 Sep; 48(9):411-6. PubMed ID: 4772413 [No Abstract] [Full Text] [Related]
19. [Changes in the indication of surgical treatment for pulmonary tuberculosis in accordance with the introduction of rifampicin based on bacteriological findings on culture of resected specimens (author's transl)]. Kekkaku; 1977 Jul; 52(7):353-60. PubMed ID: 409871 [No Abstract] [Full Text] [Related]
20. [Selection of the method of treatment for noncavitary tuberculosis cases with negative sputum for more than 6 months based on culture findings of tubercule bacilli from resected specimens (author's transl)]. Sato M Kekkaku; 1976 Aug; 51(8):329-36. PubMed ID: 824492 [No Abstract] [Full Text] [Related] [Next] [New Search]